Clinical trial
Chemotherapy and Radiation Therapy Plus Bone Marrow Transplantation in Treating…
NCT00003815 · Scotland and Newcastle Lymphoma Group, Other · Unknown status
Key facts
| NCT number | NCT00003815 |
|---|---|
| Title | Chemotherapy and Radiation Therapy Plus Bone Marrow Transplantation in Treating Patients With Aggressive Non-Hodgkin's Lymphoma |
| Official title | A Randomised Study of High Dose Chemotherapy/Radiotherapy and Autologous Bone Marrow Transplantation in Patients With High Grade Malignant Non-Hodgkin's Lymphoma (Kiel Classification) According to Prognostic Groups |
| Lead sponsor | Scotland and Newcastle Lymphoma Group, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Lymphoma |
| Intervention type | Biological, Drug, Procedure, Radiation |
| Interventions | bleomycin sulfate, carmustine, cyclophosphamide, cytarabine, doxorubicin hydrochloride, etoposide, melphalan, prednisolone, vincristine sulfate, autologous bone marrow transplantation and 1 more |
| Start date | Jun 1, 1994 |
| First posted | Jan 27, 2003 |
| Last update posted | Sep 17, 2013 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: